Hopes that a vaccine will be approved by year’s end continue to build, but questions about efficacy, manufacturing and distribution lead some to call for tempered expectations.
Hopes that a vaccine will be approved by year’s end continue to build, but questions about efficacy, manufacturing and distribution lead some to call for tempered expectations.